Data Provider / Broker · vs · Publisher & Media Owner
Clarivate vs Elsevier
Structured technology and market comparison · 2026
Direct Feature Comparison
Clarivate · vs · ElsevierResearch, library and IP workflow software and data provider.
Scientific publishing and research intelligence platform for institutions and professionals.
Analyze all overlapping signals and tech stacks for Clarivate and Elsevier
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Clarivate and Elsevier?
Clarivate and Elsevier are enterprise-focused research-information firms serving libraries, academic institutions, and IP-dependent organizations. Both offer discovery, analytics and subscription workflows, but Clarivate emphasizes curated indexes, IP management and cross-product workflow integrations, while Elsevier anchors on proprietary journal content plus publishing services and clinical/scientific decision tools. Clarivate differentiates on IP and curated indices; Elsevier on content ownership and publishing ecosystem.
How do the features of Clarivate and Elsevier compare?
Product-wise, both vendors supply discovery, bibliometrics and institutional analytics—Clarivate via curated indices, Web of Science, InCites and IP-focused tools (Derwent, patent analytics, EndNote), Elsevier via Scopus/ScienceDirect, SciVal, Mendeley and clinical/publishing platforms. Overlap occurs in citation metrics and analytics; Clarivate adds deeper patent/IP workflow and curated index granularity, while Elsevier provides broader full-text access, publishing services and clinical decision support.
What are the top alternatives to Clarivate and Elsevier?
When evaluating Clarivate and Elsevier, enterprise buyers also consider other platforms in Measurement & Analytics Platform, B2B SaaS Provider, and Productivity & Collaboration SaaS. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
Market Signals
Recent Market Signals & Activity: Clarivate vs Elsevier
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Clarivate
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Clarivate (2026-09-23)
Clarivate Plc filed a Form 8-K to report that on September 23, 2026, it issued a press release announcing the pricing terms of a previously announced cash tender offer. The tender offer is being conducted by Clarivate's wholly-owned subsidiary, Clarivate Science Holdings Corporation, targeting certain outstanding debt securities. This transaction reflects ongoing proactive liability and capital structure management aimed at optimizing the company's debt profile.
- On September 23, 2026, Clarivate Plc issued a press release detailing the pricing terms of a cash tender offer.
- The cash tender offer for debt securities is being executed by Clarivate's wholly-owned subsidiary, Clarivate Science Holdings Corporation.
- The filing was formally signed and authorized by Senior Vice President, General Counsel John Doulamis on September 23, 2026.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Clarivate (2026-09-24)
On September 24, 2026, Clarivate Plc filed a Form 8-K under Item 8.01 announcing the expiration and final results of a previously disclosed cash tender offer. The tender offer was executed through its wholly-owned subsidiary, Clarivate Science Holdings Corporation, targeting certain outstanding debt securities. The filing serves to disclose the formal conclusion of the capital structure transaction, referencing a detailed press release furnished as Exhibit 99.1.
- Clarivate Plc announced the expiration and results of a cash tender offer conducted by wholly-owned subsidiary Clarivate Science Holdings Corporation on September 24, 2026.
- The transaction targeted the repurchase and retirement of certain existing debt securities to manage the company's debt profile.
- Full details and final participation figures were disclosed concurrently via press release filed under Exhibit 99.1.
- ·Clarivate
Clarivate to Report Third Quarter 2026 Results on November 3, 2026
Clarivate announced it will report third quarter 2026 results on November 3, 2026. Additionally, the company commenced an offer to purchase for cash certain of its outstanding debt securities, and revealed the 2026 Citation Laureates.
Elsevier
Recent Signals
- ·Elsevier
Updated generative AI policies for journals: supporting responsible use while protecting trust
Elsevier updates generative AI policies for journals to support responsible use while protecting trust.
- ·Elsevier
How NHS 24 and Elsevier are turning uncertainty into confident, clinically safe decisions
The featured story on the Elsevier About page has been updated from 'The future we build could depend on research we don’t read' to a new case study about NHS 24, highlighting a partnership to improve clinical decision-making.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Clarivate and Elsevier share across the market ecosystem.
